Limits...
Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake

View Article: PubMed Central - PubMed

ABSTRACT

Background: In the absence of an adult vaccination register, coverage estimates for influenza and pneumococcal vaccination come from surveys and other data sources.

Methods: Systematic review and meta-analysis of studies examining vaccination coverage in Australian adults from 1990 to 2015, focusing on groups funded under the National Immunisation Program, and intervals prior to and following the introduction of universal funding.

Results: Twenty-two studies met the inclusion criteria; 18 used self-report to determine vaccination status. There were 130 unique estimates of coverage extracted. Among adults aged ≥65y, during the period of universal funding (1999-onwards), the summary estimate of annual influenza vaccination coverage from 27 point estimates was 74.8 % (95 % CI 73.4–76.2 %; range 63.9–82.4 %); prior to this period (1992–1998) from 10 point estimates it was 61.3 % (95 % CI 58.0–64.6 %; range 44.3–71.3 %). For the period of universal funding for pneumococcal vaccination (2005-onwards) the summary estimate for coverage was 56.0 % (95 % CI 53.2–58.8 %; range 51.2–72.8 %, 10 point estimates); prior to 2005 it was 35.4 % (95 % CI 18.8–52.0 %; range 15.4–45.2 %). Coverage for both vaccines was significantly higher following the introduction of universal funding. Influenza vaccination coverage in those aged 18–65 years with a medical indication was lower but data were not combined. Seven studies reported on Aboriginal Australians with three studies reporting five coverage estimates for influenza vaccination in adults ≥65 years (range 71 % - 89 %).

Conclusions: Adult influenza and pneumococcal vaccination coverage has increased since the introduction of universal funding, but remains sub-optimal, with pneumococcal coverage lower than influenza. Implications: This review highlights the need for more coverage data overall and in high risk groups, to support public health programs to improve coverage.

No MeSH data available.


Meta-analysis of eligible studies of pneumococcal vaccination coverage before and after the introduction of universal funding of vaccine for adults aged ≥65 years. This figure shows the results from the meta-analysis of studies reporting pneumococcal vaccination coverage, before and after the introduction of universal funding of vaccine for adults aged ≥65 years
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC5037616&req=5

Fig3: Meta-analysis of eligible studies of pneumococcal vaccination coverage before and after the introduction of universal funding of vaccine for adults aged ≥65 years. This figure shows the results from the meta-analysis of studies reporting pneumococcal vaccination coverage, before and after the introduction of universal funding of vaccine for adults aged ≥65 years

Mentions: Among adults aged ≥65 years, in 5 studies conducted prior to 2005 [3, 10, 11, 13, 26], the proportion reporting pneumococcal vaccination in the last 5 years ranged from 15.4 to 57.9 %; in 7 studies conducted from 2005 onwards it ranged from 50.3 to 72.8 % [11, 14–16, 27–29]. Coverage from 2005 onwards was significantly (p = 0.02) higher than that prior to 2005; the summary coverage estimate prior to 2005 from 4 data points was 35.4 % (95 % CI 18.8–52.0 %) versus 56.0 % (95 % CI 53.2 %–58.8 %) from 2005 (10 data points) (Fig. 3). Eight of the data points for pneumococcal coverage after 2005 came from one study [11]. As with influenza, there was significant heterogeneity in the summary estimates of coverage both prior and after universal funding (p < 0.001 for both; Fig. 3).Fig. 3


Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake
Meta-analysis of eligible studies of pneumococcal vaccination coverage before and after the introduction of universal funding of vaccine for adults aged ≥65 years. This figure shows the results from the meta-analysis of studies reporting pneumococcal vaccination coverage, before and after the introduction of universal funding of vaccine for adults aged ≥65 years
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC5037616&req=5

Fig3: Meta-analysis of eligible studies of pneumococcal vaccination coverage before and after the introduction of universal funding of vaccine for adults aged ≥65 years. This figure shows the results from the meta-analysis of studies reporting pneumococcal vaccination coverage, before and after the introduction of universal funding of vaccine for adults aged ≥65 years
Mentions: Among adults aged ≥65 years, in 5 studies conducted prior to 2005 [3, 10, 11, 13, 26], the proportion reporting pneumococcal vaccination in the last 5 years ranged from 15.4 to 57.9 %; in 7 studies conducted from 2005 onwards it ranged from 50.3 to 72.8 % [11, 14–16, 27–29]. Coverage from 2005 onwards was significantly (p = 0.02) higher than that prior to 2005; the summary coverage estimate prior to 2005 from 4 data points was 35.4 % (95 % CI 18.8–52.0 %) versus 56.0 % (95 % CI 53.2 %–58.8 %) from 2005 (10 data points) (Fig. 3). Eight of the data points for pneumococcal coverage after 2005 came from one study [11]. As with influenza, there was significant heterogeneity in the summary estimates of coverage both prior and after universal funding (p < 0.001 for both; Fig. 3).Fig. 3

View Article: PubMed Central - PubMed

ABSTRACT

Background: In the absence of an adult vaccination register, coverage estimates for influenza and pneumococcal vaccination come from surveys and other data sources.

Methods: Systematic review and meta-analysis of studies examining vaccination coverage in Australian adults from 1990 to 2015, focusing on groups funded under the National Immunisation Program, and intervals prior to and following the introduction of universal funding.

Results: Twenty-two studies met the inclusion criteria; 18 used self-report to determine vaccination status. There were 130 unique estimates of coverage extracted. Among adults aged &ge;65y, during the period of universal funding (1999-onwards), the summary estimate of annual influenza vaccination coverage from 27 point estimates was 74.8&nbsp;% (95 % CI 73.4&ndash;76.2&nbsp;%; range 63.9&ndash;82.4&nbsp;%); prior to this period (1992&ndash;1998) from 10 point estimates it was 61.3&nbsp;% (95 % CI 58.0&ndash;64.6&nbsp;%; range 44.3&ndash;71.3&nbsp;%). For the period of universal funding for pneumococcal vaccination (2005-onwards) the summary estimate for coverage was 56.0&nbsp;% (95 % CI 53.2&ndash;58.8&nbsp;%; range 51.2&ndash;72.8&nbsp;%, 10 point estimates); prior to 2005 it was 35.4&nbsp;% (95 % CI 18.8&ndash;52.0&nbsp;%; range 15.4&ndash;45.2&nbsp;%). Coverage for both vaccines was significantly higher following the introduction of universal funding. Influenza vaccination coverage in those aged 18&ndash;65&nbsp;years with a medical indication was lower but data were not combined. Seven studies reported on Aboriginal Australians with three studies reporting&nbsp;five&nbsp;coverage estimates for influenza vaccination in adults &ge;65&nbsp;years (range 71 % - 89 %).

Conclusions: Adult influenza and pneumococcal vaccination coverage has increased since the introduction of universal funding, but remains sub-optimal, with pneumococcal coverage lower than influenza. Implications: This review highlights the need for more coverage data overall and in high risk groups, to support public health programs to improve coverage.

No MeSH data available.